Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Aripiprazole in at-risk children with symptoms of bipolar disorder

Trial Profile

Aripiprazole in at-risk children with symptoms of bipolar disorder

Phase of Trial: Phase III

Latest Information Update: 29 Jun 2017

At a glance

  • Drugs Aripiprazole (Primary)
  • Indications Bipolar disorders
  • Focus Therapeutic Use
  • Most Recent Events

    • 12 Jun 2012 Actual end date (1 Jun 2012) added as reported by ClincialTrials.gov.
    • 12 Jun 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 29 Dec 2011 Planned end date changed from 1 Jan 2011 to 1 Jul 2012 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top